CrowdStrike Leads This Group Of Four Stocks To New Highs
Neurocrine Biosciences Inc NBIX
$158.42
▼ -0.40%
($-0.63)
Open
$158.22
Prev Close
$159.05
Day Range
$155.50 – $159.23
52W Range
$117.40 – $162.39
Market Cap
$15.93B
P/E (TTM)
23.82
Beta
0.37
EPS (TTM)
$6.50
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1996-05-23 |
| Shares Out. | 100,360,000 |
| Website | neurocrine.com/ ↗ |
| Phone | 18009279800 |
Neurocrine Biosciences Inc is a publicly traded company under the ticker symbol NBIX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
35 analysts (2026-05-01)
📰 Latest News for NBIX
Neurocrine Biosciences, Inc. (NBIX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Transcript : Neurocrine Biosciences, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 11
Neurocrine Biosciences (NASDAQ:NBIX) Screens as a Peter Lynch-Style GARP Opportunity
Teva's CNS Portfolio Is Growing, But Valuation Is Stretched
Soleno Merger With Neurocrine Puts Profitability And Valuation In Focus
Xenon Q1 Earnings Match Estimates, Pipeline Development in Focus
JP Morgan Maintains Overweight on Neurocrine Biosciences, Raises Price Target to $185